Evidence map›Paper›PMID 38026067›Full record

ArticleJournal of patient experience2023

Attitudes and Experiential Factors Associated with Completion of mt-sDNA Test Kit for Colorectal Cancer Screening.

Lila J Finney Rutten, Xuan Zhu, Katherine Treiman, Gabriel Madson, Brian Southwell, Leah Helmueller, Shama Alam, Carlye Gates, Linda Squiers

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of patient experience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lila J Finney RuttenDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.
Xuan ZhuDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.
Katherine TreimanRTI International, Research Triangle Park, NC, USA.ORCID https://orcid.org/0000-0001-9589-2491
Gabriel MadsonRTI International, Research Triangle Park, NC, USA.
Brian SouthwellRTI International, Research Triangle Park, NC, USA.
Leah HelmuellerExact Sciences Corporation, Madison, WI, USA.
Shama AlamExact Sciences Corporation, Madison, WI, USA.
Carlye GatesRTI International, Research Triangle Park, NC, USA.ORCID https://orcid.org/0000-0002-1431-8576
Linda SquiersRTI International, Research Triangle Park, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States. Despite the availability of multiple screening options, CRC screening is underutilized. We conducted a survey of patients (n = 2973) who were prescribed the multi-target stool DNA (mt-sDNA) screening test (commercialized as Cologuard

Indexed as

cancer screeningColorectal cancermulti-target stool DNA screening test (mt-sDNA)perceived comfortperceived ease of useperceived effectiveness

Identifiers

PMID38026067
PMCPMC10666720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.